Analyst consensus rating
Werewolf Therapeutics Analyst Rating: none
Direct answer
Werewolf Therapeutics's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked September 8, 2026.
Get free Werewolf Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.98
- Average price target
- $7.00
- High price target
- $10.00
- Low price target
- $4.00
- Low target gap
- +308.2%
- Target upside
- +614.3%
- High target gap
- +920.4%
- Target range width
- 612.2%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Werewolf Therapeutics?
Werewolf Therapeutics has a verified none consensus. The same dataset has an average price target of $7.00.
How far are Werewolf Therapeutics's low and high targets from the recorded price?
The low target implies +308.2%, while the high target implies +920.4%.
How many analysts are included in Werewolf Therapeutics's consensus?
The verified consensus includes 3 analysts.
How is Werewolf Therapeutics's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $0.98, then one is subtracted to produce +614.3%. This does not guarantee a future return.
When was Werewolf Therapeutics's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.